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CHAPTER I
THE PROBLEM
Many facets of phenylketonuria have been studied
since the discovery of the disease in 193^-«

Outstanding

among these is the mental retardation associated with
the untreated condition.

Since 1953* treatment of this

metabolic disease with diet therapy has become increas
ingly successful in alleviation of the mental retardation.
However, at the present time very few reports are
available on the influence of a phenylalanine-restrieted
diet on the growth of phenylketonurlc children.
I.

THE PROBLEM

Statement of the Problem
It was the purpose of this study:
1. To compare the mean height of male and female
heterozygotes (parents of phenylketonurlc patients) with
the mean of the normal male and female adult population.
2. To determine if treated phenylketonurlc
children differed In stature from the norms established
in the general population.
3. To determine if there was a significant
difference between stature of treated phenylketonurlc
patients with "good" control (defined as serum phenylala
nine levels equal to or less than 4 milligrams per cent)
versus those with "poor" control, when age of beginning
treatment was considered.

4. To determine the phenylalanine, protein, and
caloric intake of phenylketonurlc patients with good
control (defined as serum phenylalanine levels equal to
or less than 6 milligrams per cent) and compare this Intake
with protein and calorie Intakes recommended by the
National Research Council.
1
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Importance of the Study
Those treating the disease have observed that the
children were of smaller stature than normal children and
smaller than untreated phenylketonuria children.
Searching the literature for growth studies on the phenylketonuric revealed only one report. ^

There have been

some general references suggesting that stature is
smaller. 25, 26, 79 yet others have made statements that
treatment allowed for normal physical and mental
growth. 15, 26 Centerwall stated that both the treated
and untreated phenylketonuria tends to be smaller than
average so that "it appears the low phenylalanine diet
may have little effect on the usual pattern of physical
growth. n 25
If the phenylketonuria children were found to be
of significantly smaller stature than the normal, par
ticularly if parents compared well with the norms, a
basis would be laid for further research.

On the other

hand, if the study showed that the treated children were
of normal size, concerns related to adequacy of the
casein hydrolysate to support growth would be relieved.
II.

LIMITATIONS OP THE STUDY

Since phenylketonuria is a relatively rare disease
the sample available for this study was small.

Another

limiting factor was the lack of pre-prepared protocol on
what, how and when to collect growth and nutritional data.

3
There were inherent inaccuracies in the nutritional
data brought about by the human element as well as a lack
of nutritional data in some Instances because the parents
did not keep a three day diet record as requested before
each serum phenylalanine determination.

Complete phenylala

nine analyses were lacking and those available had been
based on few samples and old techniques so that in calcu
lation of the phenylalanine content of the diet, phenylala
nine as five per cent of total protein was used until some
time in 1965.

CHAPTER II
REVIEW OP THE LITERATURE
Research on phenylketonuria has intensified during
the past few years, and much has been published in regard
to this metabolic disease.

Only a brief summary of

related research will be presented.
Many growth studies have been reported, particu
larly during the first thirty to forty years of this
century.

Literature on growth will be cited only as it

has a bearing on standards used for comparing the growth
of the children and as it relates to conditions which
affect growth In general.
I.

LITERATURE ON PHENYLKETONURIA

History, Incidence and Etiology
In the spring of 1934 a young mother brought her
two children to Dr. Asbjorn Polling, a Norwegian
physician and biochemist, for an examination.
both mentally retarded and had a peculiar odor.

They were
When

Dr. Polling added ferric chloride to their ur^ne, a green
color appeared which he identified as being caused by
phenylpyruvic acid.

He hypothesized that the disease

"represented a disturbance in the metabolism of the amino
acid phenylalanine . . . and that this same abnormality
might be causing the retardation in these two children
and perhaps in other mental defectives. h23 In five

4

5
months* time he had identified eight other cases and had
ready for publication a scholarly report on a new meta
bolic disease which he called "imbecillitas phenyl„22, 23
pyruvica.
It is the opinion of Guthrie and Hsia that the
condition arises once in every 10,000 births in the
United States, 40, 43 however, an incidence greater than
this has been reported in some screening programs.66, 8l
The disease occurs equally in both sexes and is
found in most races, but is more common in the people of
Northern European and Japanese origin.
found among Negroes and Jews. 34, 67

It is rarely

Phenylketonuria is a metabolic disease of genetic
origin.

Jervis has shown that the disease is trans

mitted by a single autosomal recessive gene •

/

Both

parents are normal because the recessive gene cannot
gain expression unless It pairs up with another similar
gene to form the homozygote recessive state.

In the

parents, the normal gene suppresses the one recessive
gene for phenylketonuria and this condition is described
as heterozygote.

When two parents mate who both have a

recessive gene for phenylketonuria, conditions are such
that both may pair and produce offspring with the
disease.-^* 95

6
The genetic status of children born from
marriage of two heterozygote parents shows a
Mendelian distribution: 1 entirely normal, 2
heterozygote carriers (clinically normal), 1
phenylketonuric. It should be emphasized, how
ever, that this 1:2:1 ratio is statistical and
that in these families each birth Involves a 1
in 4 chance that the child will have phenylketonuria.^9
The recessive trait is carried by about one In
fifty to seventy persons in the general population 69, 78
Clinical Findings in the Untreated
Most infants with phenylketonuria are brought
to medical attention because of delayed development
in one or more areas.

The mothers notice the children

do not sit, stand, walk, or talk at the time normally
expected.
Mental manifestations.

The most striking clinical

feature of the untreated phenylketonuric is mental
retardation, evident at four to six months of age.1?,43,94
The large majority of the patients are low grade
defectives. 43, 67 Twenty-five or so atypical phenylketonurics with normal or near normal Intelligence
have been found.
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Body size, height and weight.

References In the

literature relative to size of phenylketonurics either
before or after treatment are rare.

One of the first
reports stated Mthe patients are usually well built. r»17
Centerwall, ^5 Cheek,^ and Paine 79 noted the children

were smaller than the average normal child.

Jervis

found these patients somewhat smaller than normal
individuals, but when compared with the average defective individual, they might appear larger and taller. 72
Obesity is a characteristic of the infant with phenyl
ketonuria and this sometimes leads to a mistaken diagnosis of hypothyroidism. 60
Neurological abnormalities.

Abnormal electro

encephalograms and other neurological manifestations
such as convulsions, epileptic seizures, irritability,
tremors of the hands. Increase In reflexes, temper tan
trums and hand posturing may occur with varying degrees
of severity.

43, 67, 78, 93

Extraneural manifestations.

Eczema has been

80
reported frequently. 89 vomiting in early life is common.
Phenylketonurics are often lighter in color than their
parents or siblings.^3* 67
hair Instead of black.^

Japanese patients have brown
A peculiar musty, mousey odor

is noticed in the urine and sweat and was one of the
first characteristic symptoms noted.
There is delayed dentition and enamel hypoplasia

94

8
with wide spacing of the upper incisors in some patients.
Feinberg and Fisch described the presence of calcified
spicules projecting into the epiphyseal area of the long
bones. 37
Biochemistry
Normal phenylalanine metabolism.

Phenylalanine is

an essential amino acid in that the benzene ring cannot be
synthesized in the body.

In normal individuals, ingested

phenylalanine Is used for protein synthesis and the remainder
(the greatest part) is hydroxylated to tyrosine by the
action of liver phenylalanine hydroxylase.

This Is an

irreversible reactionj two enzymes, triphosphopyridine
nucleotide (TPNH), molecular oxygen, ferrous ion, and a
pteridine like cofactor are required.

The metabolic end

products of tyrosine are thyroxine, epinephrine (adrena
line), fumaric acid, acetoacetic acid and melanin.

Some

transamination of phenylalanine to phenylpyruvic acid and
thus to phenyllactic acid takes place, but these reactions
are reversible and usually end with further catabolism
through phenylalanine.

Traces of phenylpyruvic acid may

be decarboxylated to phenylacetlc acid.

Tyrosine exerts

a sparing action on phenylalanine to the extent of about
one-half the dally requirement for growth and three-fourths
of the requirement for nitrogen equilibrium, since most
of the functions of phenylalanine are performed subsequent
to its conversion to tyrosine.70, 87, 100

9
Two enzymes are involved in the phenylalanine
hydroxylase system, which catalyzes the oxidation of
phenylalanine to tyrosine.

Enzyme I is a labile enzyme

which has been purified from rat liver and requires DPNH;
enzyme II is a stable enzyme and requires oxygen, TPNH
and tetrahydropteridines.

This second enzyme is not

involved in the hydroxylation reaction, but merely
catalyzes a reaction which keeps the coenzyme in an
active form so that the hydroxylation can take place.^
In Figure I the usual pathways for phenylalanine
and tyrosine metabolism are outlined.
Jervis demonstrated that the inability of the
phenylketonuric to metabolize phenylalanine was due to
a defective oxidizing system for converting phenylalanine
to tyrosine.^

Later he showed that phenylalanine

hydroxylase activity Is not present in the liver of
patients with phenylketonuria, 51 By the use of radioactive phenylalanine. It was found that the phenylketonuric could oxidize phenylalanine to tyrosine about five
per cent as well as normal Individuals.

16, 98 Armstrong

states that ten per cent of the phenylalanine is oxidized
to tyrosine.

It is now known that phenylketonuria Is
■34
caused by a deficiency of Enzyme I.
Regarding the
hereditary enzyme defect, Hsia states:
All we can say is that the enzyme . . . does
not appear to be working properly (the enzyme has
not been crystallized, and there is no physical
means of showing whether it is present or absent).

ortho-OH phenylacetic acid

PHENYLALANINE

TRYPTOPHAN

Phenyllaotic acid
hydroxylase
Phenylpyruvic acid

'YROSINE

Phenylacetic acid
,4 djLhydroxyphenylalanine
(Dopa)

>/

5-OH tryptophan

Indolepyruvic
acid

5-OH tryptamine
(Serotonin)

Indolelactic
acid

V/
5-OH indoleacetic
acid

Indoleacetic
acid

Thyroxine
Melanin
Nr

Phenylacetylglutamine
Norepinephrine
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Homogentlsic acid
Fumaric acid
Epinephrine
Acetoacetic
acid
Heavy line - Main normal metabolic routes
Lighter lines
Alternate routes used as
main routes in the phenylketonuric.
FIGURE 1
METABOLISM OF PHENYLALANINE, TYROSINE, AND TRYPTOPHAN SHOWING
BLOCKS THAT OCCUR IN PHENYLKETONURIA
i—1

o
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This can occur because the enzyme molecule is com
pletely absent and hence is unable to do its work.
More likely, the protein molecule is present but
there is a genetically determined mutation at the
reactive site. It Is probable that, as in the
abnormal hemoglobins, there has been an amino acid
substitution so that the enzyme-substrate reaction
cannot take place properly, and one is given the
impression that we are dealing with an inactive
enzyme. Finally, it Is possible that the enzyme
could be both present and structurally normal but
unable to function properly In the environment
because of alterations In the host or within the
cells. A deficiency of cofactors or the presence
of inhibitors could produce such an effect.^3
In the absence of phenylalanine hydroxylase
activity, a group of minor pathways of phenylalanine metab
olism, little used in normal individuals, become promi
nent.

Transamination of phenylalanine yields phenyl-

pyruvic acid (which forms the green color in the presence
of ferric chloride).

Accumulation of this product leads

to formation and excretion of phenyllactic acid, orthohydroxyphenylacetic acid, and phenylacetic acid (respon
sible for the odor associated with the disease, the
latter appearing In the urine as phenylacetylglutamine).
Phenylalanine and phenylpyruvic acid (this usually
predominates) are also excreted In the urine.

A normal

excretory product, metahydroxyphenylacetic acid, is
absent or greatly diminished in quantity. 13, 21, 34, 70, 94, 100
There are increased amounts of indolelactic, indoleacetic and indolepyruvic acids In the urine Indicating
that a disturbance of tryptophan metabolism is associated
with phenylketonuria.

The serum level of serotonin, five-

hydroxy-lndoleacetlc acid and other hydroxylated deriva-
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tlves of tryptophan are lower In the untreated phenylketo
nuria, showing a close inter-relationship in the hydroxylation of aromatic amino acids, 68, 70, 94, 101 It has
been found that the same enzyme which hydroxylates phenyl
alanine also hydroxylates tryptophan to five-hydroxytryptophan, the precursor of serotonin, 16, 70 Fhenylalanine metabolites have an Inhibitory effect on fivehydroxytryptophan decarboxylase. 34
The decreased pigmentation in phenylketonuria
results from the competitive Inhibition of phenylalanine
on the tyrosinase system which catalyzes the first step
and accelerates the second step in the metabolism of
tyrosine to melanin.

If the intake of tyrosine is

increased or the intake of phenylalanine lowered (as in
treated patients) the hair and skin become darker.^* ^7* 94
There are no detectable abnormalities in the amino
acid composition of proteins of various tissues, or serum
proteins, or of hemoglobin In the phenylketonuria. 15, 34, 67
The phenylalanine level In the cerebrospinal fluid is onefourth of that In the plasma.^

There is an altered

pattern of plasma amino acids; the alpha amino nitrogen
of the phenylalanine found in phenylketonuria is about

/

half of the normal total alpha amino nitrogen of plasma,
yet the total alpha amino nitrogen in the plasma Is not
substantially higher than normal.

The high phenylalanine
\ \

content evidently causes a depression of the concentration
of most other amino acids.

Glycine is present at a

/

13
normal level and histidine at an increased level. 70, 89, 94
Figure I, page 10, shows the main alterations of
metabolism of phenylalanine and tryptophan in the phenyl
ketonuria .
Treatment
Since the clinical symptoms of phenylketonuria

r\

result from the accumulation of phenylalanine and its
metabolites in the body, treatment is aimed at reducing
these biochemical compounds.

This is accomplished by the

use of a phenylalanine-restrieted diet.
Bickel and coworkers (1952) were the first to
devise a low phenylalanine diet which they administered
to a phenylketonuria.

Blood phenylalanine was reduced

and phenylpyruvic acid in the urine disappeared.^
Early diagnosis and dietary treatment are of
utmost importance in preventing the associated mental
changes.

58, 61 In older children, increase in intelli-

gence cannot be expected, but clinical symptoms
improve. 18, 45, 67
The major source of nutrients In the phenylalaninerestricted diet is supplied by the use of a specially
processed protein hydrolysate, low in phenylalanine.
This amino acid is purposely low so that the phenylala
nine requirements may be adjusted to meet the individual^
requirements for growth.

This Is accomplished by the

judicious addition of a wide variety of natural foods.

14
thus allowing the phenylketonurlc*s diet to be as near
normal as possible. 14, 61, 67, 99
The diet and Its nutrients.

The optimal daily-

intake of phenylalanine for the phenylketonurlc infant
has been estimated to be forty to twenty milligrams per
pound each day^ with a gradual decrease of requirements
on a weight basis with Increasing age in each child.1 , 2, 24
The phenylalanine requirement for the normal infant is
qp

forty-one milligrams per pound per day. ^

Others have

reported considerable variation in the amount of phenyl
alanine needed by phenylketonurics during the first year
of life, both from infant to infant, and at different
times in the same infant. 56, 100 Two and a half to
seven milligrams per pound per day has been set as the
possible daily needs of a fifteen year old phenylketonuric boy.

p

A

Phenylalanine requirements vary but rise to a
maximum when body protein is being formed at the
highest rate. This parallels rapid growth which
occurs during the first year of life. The time
and degree of this peak varies from infant to
infant. Older children usually have a relatively
lower requirement, but their tolerances are variable
also . . . All low-phenylalanine diets must be
tailored and altered according to the individual
child*s tolerances and requirements.99
The protein need of phenylketonurics may be higher
than for the normal child since the protein is in the form
of a casein hydrolysate.

At the present time one and

three fourths to two grams of protein per pound is
recommended for the infant up to three months of age and
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one and a half grams for the infant from four months to
a year. 89

These recommendations are higher than those

for the normal baby.
Caloric intakes of phenylketonuric children on the
low phenylalanine diet have been higher than the National
Research Council recommends. 47, 84, 100

Centerwall

suggested sixty to sixty-five calories per pound per day
for the infant with phenylketonuria.
Treatment and growth.

oh

Very little appears in the

literature with the exception of general statements that
a phenylalanine level should be maintained which will
allow for satisfactory growth and that if this level is
too low, growth responses will be inadequate.

Centerwall

stated "the children generally had somewhat slow growth
patterns but were well nourished for their heights. n25
Of the six children who were started on the low phenylala
nine diet after eight months of age, five maintained a
growth pattern similar to that of the pre-diet period.
He reported significant drops in percentile levels in the
babies who were started on treatment before two months of
age.

In conclusion he wrote:
Observations on physical growth show that the
children^ heights tend to be below average, but
their weights have been in good proportion to
their heights. In that untreated children with
phenylketonuria also tend to be smaller than
average, it appears that the low phenylalanine \
diet may have little effect on the usual pattern:
of physical growth.25
y
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On the other hand. Cheek stated that the use of the low
/

phenylalanine diet improved both mental and physical
status,2^ and Bessman says "the majority of the cases
found and placed on the diet grow normally, both physically
and mentally. nl5
A German scientist observed significant retardation
of growth in children suffering from phenylketonuria and
treated with a low phenylalanine diet, compared with
untreated phenylketonurics.

There was a retardation of

bone age and a thickening of the metaphyseal plate, which
he felt was due to changes in amino acid balance.This
same author reported that growing rats fed with protein
hydrolysate low in phenylalanine showed definite growth
inhibition, but with the addition of phenylalanine and
tyrosine, retardation of growth was prevented.

Further

studies on the rats "revealed definite structural and
biochemical changes mostly in the epiphyseal growth area. "32
That there may be definite changes in bone growth
has been shown by others.

Feinberg and Fisch studied a

group of thirty-three patients at the University of
Minnesota Hospitals; five in the younger age group showed
unusual bone changes in growing long bones.

Serum calcium,

phosphorus and alkaline phosphatase were in the normal
range and they did not think that diet was related to
the cause of changes in the long bones.37

However,

Murdock and Holman followed two phenylketonurics from
infancy and found a direct correlation between diet.

IT
serum alkaline phosphatase, and epiphyseal spiculation.
’’Both patients exhibited subnormal bone growth, decreased
weight gain, and lowered serum alkaline phosphatase
levels, corrected by increasing dietary phenylalanine. «77
Hsia states that calcified spicules have been found to
project into the epiphyseal area of long bones and
cupping occurs in the metaphyseal plate, along with
osteoporosis which he attributed to protein mal
nutrition. 46
Termination of dietary treatment.

Various ages

have been proposed as to time the diet might be
discontinued. 4, 22, 102 Horner reported termination of
dietary treatment at four years of age on three children
with phenylketonuria, treated from earliest infancy, and
found no deterioration of mental development. 42 However,
Koch cites a case which had been treated from sixteen
months to four years of age.

At age six and a half the

child was brought to his clinic when she began to
experience psychomotor seizures.

He states that dis

continuance of diet therapy may be hazardous and
recommends caution when considering it. 89

At the present.

both Koch and Bickel continue diet therapy at least
until adolescence. 59, 60, 67
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II.

LITERATURE ON GROWTH

Today there is no lack of literature on growth and
its many aspects,

In fact, the "pediatrician and his

ancillary colleagues may well be overwhelmed by the quan
tity of data, charts and grids concerning growth that
have appeared in the last 20 years. "35
Assessment of Growth
Ideally, growth and development are assessed
through observations and measurements obtained from
pediatric examinations, health and dietary records,
x-rays, anthropometric measurements, dental examinations,
measures and observations on the skin, hair, muscle and
subcutaneous fat, observations of sexual maturation and
biochemical tests.

Practically, the investigator usually

has to settle for those observations and measures which
are directly concerned with his purpose for the research.
Since this study is concerned with anthropometric measure
ments and dietary records, the discussion will be limited
to these phases.
Anthropometric measurements.

There is a minimum

of lengths and circumferences which should be maintained
In any growth study.

Garn has slightly modified those

which were recommended by the Committee on Nutritional
Anthropometry, Pood and Nutrition Board, National
Research Council In 1956. 28 In the listing, the
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measurements are rated from A (absolutely essential)
through E (desireable but rarely practical In the field).
This listing follows:^
Birth and 1 month
A.
B.
C.
D.

Length (crown-heel and crown-rump) and weight.
Head circumference, chest circumference.
Bicristal diameter.
Pat-folds at triceps, below the scapula and
on the chest at the mid-axillary line.

During the first year
A.
B.
C.
D.
E.

Lengths (including stem length) and weight.
Head, chest, arm, calf circumference.
Bicristal diameter.
Fat-folds.
Postero-anterlor hand x-ray.

1-6 years
A.
B.
C.
D.
E.

Lengths, standing height and weight.
Circumferences, excepting head after 3 years.
Bicristal and bisocromial diameters.
Pat folds.
Hand x-ray.

Prom 7 years on.
A.
B.
C.
D.
E.

Lengths, height and weight. Ratings of sexual
maturation.
Chest, arm and calf circumference.
Bicristal and bisacromial diameters.
Fat folds.
Hand x-ray.

Reasonable care should be exercised that these
measures be taken with accurate, readable scales, calipers,
and tapes.

Weight should be taken after the bladder has

been emptied, clothing should not be a variable factor.^
In order that there may be an accurate comparison
with established norms, measurements and observations
should be made at constant intervals. 7 ideally on the
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subjects birthday or half-birthday or at other preHowever, this is usually not possible

determined ages.

and it is reasonable to allow for small tolerances,

Garn

suggests plus or minus 1 day until 3 months> 2 days at
six months, 4 days at one year, etc •» ending with plus or
minus 25 days at 7 years of age.^

Interpolations are not

the best as velocity of growth varies with age and also
with adverse Influences. 71 The children in the Brush
Foundation Study were measured within a week of their
birthday. 91
As an indicator of growth, height is fairly stable,
whereas weight is influenced by many factors and may
fluctuate greatly.

A weight measure can be lost in

disease, malnutrition or dieting, whereas height is not.
It is necessary to know whether weight represents water,
muscle, bone or fat.^^

Simmons states that "as a measure
of growth, stature is superior to weight, ».91 Holt 41 and

Lowe

65 state that weight gain is adequate for assessing

nutrition.
X-rays.

The use of x-rays to determine skeletal

maturity is a relatively simple and effective tool in
assessing growth and is reasonably independent of body
size. ^

It is the most widely used method of determining
54, 62
biological age.
The Atlas of Greulich and Pyle^^ is the standard
of reference generally used in the United States for
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the determination of bone age. 53

An x-ray of the left

hand is made and the number of calcified centers and the
amount of calcification is matched with a standard set of
films, each representing an average child at a particular
age. 55

when the nearest matching film has been found, the

age from this film becomes the ’’bone age" of the child
whose skeletal maturity is being assessed.

Growth time

available to the child is related directly to the degree
of skeletal maturity exhibited. 11, 53
One measure or film will give the status of the
child at that time and has some use, but rate of progress
seen through successive films is of more value in evalu54
ation of growth.
Dietary records.

Nutrition is an important factor

for investigation in relationship to the various aspects
of growth, development, and health of children.

Dietary

records should be both qualitative and quantitative, and
’’should be made in conjunction with a competent nutri
tionist, preferably one with research training and field
experience. H 38
Growth Studies
Ideal patterns of growth for healthy children are
not known, though many studies provide data for growth on
selected populations.
The Iowa growth charts used regularly In pedia
tricians1 offices were based on 13,000 cross sectional
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height and 11,000 weight observations of Iowa city boys
and girls between 1920 and 1940.
the higher socio-economic group.

The majority came from
49

The Brush Foundation Study (1931-1942) was longi
tudinal in nature.

The 999 children studied were a

sampling of the Greater Cleveland child population
selected on the following basis:

l) voluntary partici

pation, 2) agreement to continued participation, and
3) freedom from gross physical and mental defects.

The

parents were from above average economic and educational
status, all white, and of North European ancestry.

The

children were measured while dressed in indoor clothing
with shoes removed. 90 This is the study on which Greulich
and Pyle*s Atlas was based.

Two other well known longi

tudinal studies are the Harvard and Berkeley studies. 8,9,96.97
Growth Patterns and Hate of Growth
The growth of normal children is continuous but
not necessarily uniform from one age to the next; there
are periods of both rapid and slow growth.

In general

all children grow rapidly the first year, slowly from
then until the pre-adolescent growth spurt.
At birth and during the first year of life, boys
are slightly heavier and taller than girls.2+1

Sex

differences tend to be negligible from about three years
through ten to eleven years. 90 when girls exceed boys
In stature.^

From this age until thirteen, the girls
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are taller, after which the boys catch up and pass.

Boys

mature approximately two years later than girls with the
pre-adolescent growth spurt coming between the ages of
eleven to fourteen.

This growth spurt manifests itself
between ages nine to twelve in girls, 41, 90 If there is
an unfavorable environment for growth, there is a lagging
rate of skeletal maturation.

Males are more subject to

this maturation lag than females. 33, 53, 62
There are two sets of growth factors, one which
determines the ultimate size of the individual and one
which determines the speed at which the individual will
attain this size. 53 The extra tall girl may be closer
to maturity than the shorter one or she may have a much
greater growth potential.
The growth curves for height and weight have been
derived from averages of the measurements of large
numbers of children at each age.

For children under nine

years, this method Is acceptable, but after this age,
comparing an individual child with the average can be
very misleading since the prepubertal growth spurt can
come very early or very late (and yet be very normal for
this Individual) and this spurt Is much more rapid than
is indicated by the curves of averages. 9
Reed and Stuart report a wide range of variation
observed In the growth curves of height and weight in
their series of 134 children.

They found that ’’the rate
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of growth during early childhood, i.e • 9 before 6 years of
age was associated with, but not specifically predictive
of, size at maturity and timing of the adolescent growth
spurt.

Individuals with rapid growth before 6 years of

age tend to have large mature size and early adolescent
growth spurt. m85
It has been shown that children shift through more
of the stature range during the early period of life and
hold their approximate position during the middle period
of childhood. 71, 90 Thus, self-predictability of stature
is poorest during infancy and can be predicted somewhat
more accurately at an age before the pre-adolescent
spurt.
In addition to periods of both rapid and slow growth
naturally occurring in normal children, there are sudden
spurts, often termed “catch up phase of growth” after an
adverse circumstance such as illness or malnutrition has
been removed. 41, 83 Cravioto found that when young, mal
nourished children were placed on a good diet, the rate
of growth was very fast at the beginning of the rehabili
tation period, but slowed later on.

The initial rate

corresponded to the actual size of the child.

However,

growth ceased at the usual chronological age, and the
child became an undersized adult.^9

This Is in line with

Mitchell^ findings that “full growth potential must be
used continuously If full development is to be achieved. «»74
However, Holt states that If the duration of growth
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arrest has been short, the sudden spurt or "catch up"
phase may compensate entirely for the growth arrest.
There has been an increase In stature and weight
in many countries during the past hundred years, thus
the age at which a child attains a given height or
weight has been reduced. 36, 41, 57, 62, 72

However, this

secular Increase in height and weight seen in the United
States during the last century may be at an end.

Infants

studied recently show the same growth pattern (length
and weight) as well cared for infants from the same area
thirty years ago. 88
Factors Which Influence Growth
There are many factors which Influence growth and
to do a thorough review of all would be quite impossible
and much beyond the scope of this present research,

Hence,

this review will be brief and cover those factors impor
tant for this study.
Genetic Influences.

The rate and pattern of growth

and body size an individual attains is determined by
genetic and environmental factors. 28 This hereditary
background has been estimated to be as much as eighty per
cent of all influences.

Bayley found that there was an

increasing correlation between the child's height and that
10
of the parent of the same sex as the child grew older.
Kagan and Moss have cross-validated this parent-child
cc

relationship.
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Mitchell states that each child inherits genes for
height and shortness, but that it is the inheritance from
the taller parent that predominates.
X-rays reveal that genetic control is linked not
only to variation in ossification patterns but also to
the speed at which these develop. 28, 53
Studies of the relationship of rate of growth and
nutrient intake suggest that infants have genetically or
physiologically predetermined maximums of statural growth
which they could not exceed no matter how much they
increased nutrient intake. 88

Thus, it is seen that final

stature is limited by heredity, but whether or not the
individual realizes his full potential is determined by
environmental factors. 28
Endocrine influences.

The anterior pituitary.

thyroid, adrenal cortex and gonads secrete hormones which
influence the rate and timing of growth.
is a very complex one.

This Influence

At the present time very little is

known about the factors which control the rate of
secretion of the growth hormone, somatotropin, by the
pituitary.

41, 49

Birth weight and subsequent growth.

It has been

suggested that birth weight may be connected with later
growth.

"A striking high proportion of children of the

smallest birth weight were far below the ‘normal* weight
in later childhood . , .

There were similar but less
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striking changes in the mean height of these children at
n48
all ages.
Climatic and seasonal Influences.
study was reported by Lloyd-Jones.

An Interesting

He found Los Angeles

Public School children in 1937 to be superior in height
and weight to any other group and concluded that this
superiority must "in part be put down to environmental
influence in that area. n64
Holt states that season affects growth and he found
weight gain to be greater in late summer and fall than
in winter, spring or early summer. 41 However, Prader,
Tanner and von Harnack report that a minority of children
regularly grow faster in height in spring and summer.

One

child showed a springtime velocity nearly double the
autumn rate. 83
Nutritional influences.

The relationship of good

nutrition and physical growth has long been recognized.
Minimum requirements for many nutrients have been estab
lished.

In the United States today efforts are being

made to establish optimal levels and even maximal levels
of nutrient intake compatible with health. 12
As mentioned previously, the growth of infants now
is about the same as twenty years ago for the same area
of the United States.

This would indicate that with

optimal nutrition, there has been no further increase in
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growth.

The nutrition of these children has allowed them

to obtain their genetic potential but increases past this
point do not occur.

28, 86, 88

Arrested growth occurring in conjunction with
severe nutritional deficiencies has been noted with
increasing frequency in developing countries.

However,

there must also be a class of children in whom nutri
tional limitations are such that frank clinical symptoms
are absent, yet who do not reach their full growth poten
tial because of these limitations.^
The extent to which undernutrition influences the
size of an individual depends upon the age at which it
occurs, the greatest effect being at the period of maxi
mum growth, and its duration in relation to the total
period of growth,

33 Dreizen compared the height and

weight of 56l children with chronic nutritive failure
with a group of adequately nourished, ethnically compar
able children from the same geographic region.

The under

nourished children showed a substantial lag in height by
the third year of age; this lag increased progressively
in the boys while it remained constant in the girls.
Several examples of nutritional limitation are
cited by Mitchell.

Viennese children after World War I

were two to three years behind in height and weight.
Growth of children in Stuttgart, Germany, was compared
and a significant difference was observed between those
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from the low Income families and from upper income families.
In both there was a leveling off or drop in stature after
the two world wars and a period of unemployment In the
early 1930's.

A survey of Guam children in 1947 showed

all to be retarded In height, weight, and skeletal
maturity. 75
Japanese data, where heights and weights of all
school children had been recorded annually since 1900
showed a steady increase In stature until 1939.

When the

heights were again recorded after the war (1948), stature
at every age was less than it had been in 1939.

Since

that time, there has been a steady increase in height
along with concommltant Increase of animal protein
consumption.

To find whether this increase was due to

better nutrition, the author studied data from twentytwo orphanages.

These children were smaller In stature

than Japanese youth in general.

When the nutrients from

the foods used in the institutions were calculated. It
was found that animal protein was a serious limitation.
The Pood and Agriculture Organization protein scores
varied from sixty-seven to seventy-four in these orphan
ages.

The limiting amino acids were tryptophan, the

sulphur-containing amino acids, or both in all the
institutions.

These findings seem to "corroborate the

theory that better nutrition, and particularly more
adequate protein, are significant with respect to
stature. h75
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A retardation of skeletal age is evident when there
is chronic malnutrition;

there may also be

a consider

able frequency and variety of anomalies in the bones of
the hand skeleton. ««33

Bone growth depends primarily on

the proliferation of cartilage cells before calcified
bone can form.

This mechanism is very sensitive to both

qualitative and quantitative limitations of protein.
Since cartilfiige is protein and the growth
mechanism is extremely sensitive to a protein
limitation, it is understandable that physio
logic growth may slow down or stop when the
protein supply is limited in quality or quantity
. . . The first reaction of young bone to growthimpeding factors is localized in and around the
cartilage cells. The number of these cells is
reduced as new bone production is limited.
Apparently then this mechanism may be affected
by a mild protein limitation when there are no
other signs of a deficiency.75
When malnourished children are treated with pro
tein supplements, epiphyseal calcification progresses
more slowly than weight.
The Harvard Growth Study included a nutritional
study by Burke.^

A comparison of her findings with the

National Research Council Recommended Allowances showed
average values for nutrient intake and especially protein
to be higher than those recommended.
Enormous differences between individuals of the
same age and sex are equally obvious in the findings.
At every age, for both sexes, and for both calories
and protein, there was at least one child whose
intake was approximately twice as high as that of
one or more other children of the same age and
sex ... It was evident that many children varied
widely from the average pattern In both level and
rate of change in Intake from year to year.19
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Rueda-Williamson conducted a longitudinal study of
sixty-seven infants from two to fifteen months of age;
his report relates growth and nutrient intake simultan
eously.

These infants were from the same geographic area

and ethnic groups as those who had participated in the
Harvard Studies.

The infants had high caloric and very

high protein intakes as compared with the National Research
Council Recommended Allowances.

"The correlation between

length increment and calorie or protein intake was not
significant.

The correlation coefficients between weight

increments and calorie intake were significant but
low.” 88
Nutritional studies were added to the program of
the Denver Longitudinal Study in 1946.

Beal presents

data on height of these children to show the variety of
individual patterns attained.

Two boys had a similar

caloric intake and weight but the second boy had consid
erably wider fat layers.

Two other boys had similar

caloric intake but were alike in height only.
girls compared varied as much.

The four

It was concluded that

caloric intake alone "cannot be expected to have a high
positive correlation with weight gain. „12
The dietary pattern of Indian pre-school children
was correlated with height and weight.

Those receiving

the most protein showed the greatest increase in weight.
Heights did not differ significantly.
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Mental deficiency and retarded growth.

There are

conflicting opinions regarding the relationship between
mental deficiency and physical growth.
Kugel and Mohr:

Quoting from

"Many are of the opinion that the

factors which operate to produce mental debility also
seem to produce a general physical inferiority, others
emphatically maintain that this relationship is slight
or even non-existent. »63
Skeletal age has been found to be closely corre
lated with chronological age and not delayed in the
mentally retarded.

However, if these patients were

divided into diagnostic categories, those with disorders
of metabolism exhibited the greatest percentage delay in
82
bone maturation.
Cravioto proposes that malnutrition in the very
young individual may produce mental retardation that
does not repair with dietary restoration.

In five

different communities of Mexico and Guatemala he found
high correlations between deficits in height and weight
29
and developmental scores.
A recent cross-sectional survey of physical
measurements on Caucasian institutionalized mentally
defective patients showed a positive correlation of
height and weight with intelligence in both sexes.
The fact that these patients were institutionalized
might in itself have had a bearing on their height and
weight.

Some are of the opinion that institutionalization
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tends to lower the Intelligence quotient due to lack of
stimulus in the social situation and this could be a
factor in appetite.

Also, the diets might not be taken

as well due to inability to self-feed,

Perhaps nursing

does not have as much time and interest to help the
patient with his food as the interested family members do.
However, research at a Child Development Clinic confirms
the positive correlation of intelligence and physical
growth.
The degree of physical impairment is related to
the severity of mental retardation. Regardless of
the cause of the disorder, the data presented
support the conclusion that the degree of mental
retardation and the degree of physical growth
deficiency are related, and that the greater the
mental defect, the more checked will be the physical
growth . . .
While it is clear from this study and others
that there is an association between physical
development and mental development, it is not clear
whether this is a cause and effect association . . .
The supposition that brain defect can of
itself produce physical growth retardation, may
be a reasonable hypothesis.^3
Gulley found that profoundly retarded children,
with or without motor dysfunction, were shorter and
lighter for their age than higher functional children.
On the other hand, it is reported that Servian children
“who had been seriously undernourished in infancy were
found at schoolage to have normal physical characteristics but subnormal mental capacity. «20
Summary
Growth is dependent on a great many genetic and
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environmental factors.

Control rests In the continuous

interplay of these forces operating through the endocrine
and nervous systems.

Harmony among these forces results

in orderly growth progress; disharmony may lead to
bizarre growth disturbances.^

CHAPTER III
METHODS OP PROCEDURE
The methods of procedure are discussed under three
general classifications:

1) selection of the subjects

and data, 2) collecting and recording the data, and
3) analysis of the data.
I.

SELECTION OP THE SUBJECTS AND DATA

Data utilized for this study was secured from the
medical records of phenylketonuric patients of the Child
Development Clinic of Children^ Hospital, Los Angeles,
California.

At this clinic the children were seen at

regular intervals on an outpatient basis for evaluation
of medical and developmental status.

Data from forty-eight

medical records was used for the statistical analyses and
In some instances this number was further reduced.

The

number of cases and/or measures are listed in each table.
The criteria for selection of the subjects for the
growth study were:

1) there must be serial measurements

of patients height, and 2) there must be serial serum
phenylalanine determinations.
The criteria for selection of the data for the
nutritional study were:

l) the serum phenylalanine level

must be equal to or less than 6 milligrams per cent.
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2) records of simultaneous serial phenylalanine, protein
and calorie intakes must be available, and 3) records of
simultaneous weights must be available.
II.

COLLECTING AND RECORDING THE DATA

The following data were collected from the medical
records:

birth date of the child, serial heights and

weights, bone ages, serial serum phenylalanine levels in
milligrams per cent, intakes of phenylalanine in milli
grams per day, protein in grams per day, and calories
per day, with the date of each measure and/or observa
tion.

Pather*s and mother’s heights were also recorded.

Age records were to the nearest whole month, inches
were to the nearest one fourth, ounces were to the nearest
tenth of a pound.

Height and weight measurements before

2 years of age were made without clothing.

After two

years of age, only the shoes were removed.

Standing

height was used as soon as the child could stand erect.
Intakes of phenylalanine, protein, and calories
were calculated from three day diet records kept by the
parents immediately before the blood specimen was
obtained for determination of serum phenylalanine.

Cal

culations of protein and calories were based on analyses
27
Data
listed in Pood Values of Portions Commonly Used.
for calculation of nutrient content of the casein hydrosylate (Lofenalac) was based on manufacturer^ analysis.
Previous to July, 1965, phenylalanine was calculated as
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five per cent of all protein; after this date, phenylalanine
was determined from the analyses listed in Pood Values of
Portions Commonly Used2^ and Journal of the American
Dietetic Association,73
III.

ANALYSIS OF THE DATA

Parents1 Height
Analysis of parents* height consisted of obtaining
the mean and comparing this with the mean for the adult
white American male and female.3
Height of Phenylketonuric Children
Statistical procedures were applied to the following
hypotheses as Indicated:
Hypothesis I.

The mean of the last reported height

of phenylketonuric children Is less than the mean of the
expected heights.
The z test for large sample correlated data was
used to test the significance of difference between means
of the last recorded height of treated phenylketonuric
children and normals.
Z *

The following formula was applied:

Ma

Ml

+

m2

2

- 2r 1 2

(^mg)
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Where

« mean height of normals and Mg = last recorded

height of phenylketonuria patients.
Existing norms from the Brush Foundation Study
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were used as a basis for comparison of the growth data
in this hypothesis.

Since the children in this study

were not measured exactly at ages which correlated with
those of the normal growth study, it was necessary to
interpolate the norms to arrive at the age on which the
measurement used for the analysis was taken.
Hypothesis II.

Phenylketonuria children whose

treatment was instituted at or before six months of age
are shorter than those whose treatment was instituted
after six months, when the two groups are made comparable
(by covariance) in terms of mean height at time treatment
was started.
Hypothesis III.

Phenylketonuria children under

"good" dietary management are shorter than those under
"poor'1 control when the two groups are made comparable
(by covariance) in terms of mean height at time treatment
was instituted.
Hypothesis IV.

Phenylketonuria children whose

treatment was instituted at or before 6 months of age
under "good” control and those treated after 6 months of
age under "poor” control differ in height from those who
were treated at or before 6 months under "poor” control
and after 6 months under ’’good” control.
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Hypotheses II, III, and IV were analyzed using the
The covariate was the height at

analysis of covariance.

time treatment started after the data was transformed by
the following formula:

E), where A = actual

(A
E

height, E = estimated height, i.e * i mean of normative
data at same age as case,

This was simply a means of

making the heights comparable at beginning of treatment
through a statistical procedure, so that if there was a
later difference, this would have significance.
In testing Hypotheses II, III, and IV, the groups
were divided according to control and age.

Patients

described as having ’’good" control were those whose
serum phenylalanine levels were equal to or less than
4 milligrams per cent, 75 per cent of the time,

Those

in the "poor" control group had serum phenylalanine
levels greater than 4 milligrams per cent greater than
75 per cent of the time,

It should be noted the criteria

of "good" and "poor" control in the growth section was
based on a different serum phenylalanine level than the
criteria for selection of the data used in the nutritional
section.

It Is the opinion of some investigators that

very low serum phenylalanine levels cause growth retar
dation.

For this reason, a lower level was chosen for

this section of the study.
Groups were further divided according to age of
beginning treatment; I.e • t one group was 6 months of age
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or less at beginning of treatment, the other group was
over 6 months of age at beginning of treatment,

Thus,

four groups were formed with 6 patients in the "younggood" group, 6 in the "young-poorM group, 10 in the
"old-good" group, and 26 in the "old-poor" group,

This

method of comparison is illustrated by the following
diagram:

_______________ ____ ______________ _
1

C
0
N

0

N=10

3

"young-good"

"old-good"

mg.
75^ of
time
2

T
R

N=6

> 4
mg.
75# of
time

L

N=6
"young-poor"

6 months

4

N=26
"old-poor"

> 6 months

Nutritional Data
For analysis of the nutritional data, the ages of
the patients were divided into intervals by months and
nutritional data was obtained (only if the simultaneous
serum phenylalanine level was equal to or less than 6
milligrams per cent) for the following groups:
Group 1.

0 <3

Group 4.

10<12

Group 6.

37< 72

Group 2.

4<6

Group 5.

13<36

Group 7.

731108

Group 3.

7£9
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Means and standard deviations of Intake of phenylalanine,
protein, and calories were obtained.

Protein and calorie

Intake was compared with the National Research Council
Recommended Allowances for the various ages.

i

•/ .

£.
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CHAPTER IV
RESULTS AND DISCUSSION
The results are discussed under two general
headings:

growth data and nutritional data.
I.

GROWTH DATA

Parents1 Heights
Since heredity plays such a large part in the
>

stature of an individual, the parents* heights were com
pared with the mean height for the American white male
and female.

There were 36 sets of parents* heights

available for use in this part of the study.

The range

of the fathers* heights was 61.50 to 78.00 inches with a
mean of 69.83 inches as compared to 69.68
American white male.

inches for the

The range of the mothers* heights

was 57.50 to 71.75 Inches, with a mean of 64.49 inches
as compared to 64.17 inches for the American white
female.

The mean height of parents of phenylketonuria

children was slightly above the mean height for the
average white American, though only slightly so.
Hypothesis I.
/■

This hypothesis deals with the comparison of the
heights of the treated phenylketonuria children and normal
children.

The mean height of the research group at time

of beginning treatment was 32.55, the mean of normal
42
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children's heights at the same ages was 33.11, a diff
erence of approximately one half inch.

The mean of the

latest measured height of the research group was 40.96,
the mean for the normal children's height was 42.36, with
standard deviations of 8.91 and 8.42, respectively.

The

difference of 1.40 inches would seem to indicate that
treated phenylketonuric children were shorter than the
general child population.

The z test was applied to

determine if the difference between the means of the
treated phenylketonuric children and the normals was
significant.

Very significant differences were found.

A probability of <, .001 indicated that the children in
this sample could not have been drawn from the normal
population more than 1 time in 1,000 if only chance
differences were occurring.

The conclusion reached was

that treated phenylketonuric children were shorter than
normal children.

This difference in stature could be

due to one and/or several unknown factors.

The disease

itself may cause the growth retardation or there may be
diet related factors, one of which could be an amino acid
imbalance.
Hypothesis II
When the last recorded heights of the phenylketo
nuric children were analyzed (by analysis of covariance)
considering time of beginning of treatment, i.e • > those
started on treatment

6 months of age versus those
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started on treatment after 6 months, it was found that
there was no signifleant difference between the two groups
in terms of their last measured height,

The conclusion

was that age treatment was instituted in the phenylketonuric children makes no difference in their later
heights.
Hypothesis III
Hypothesis III evaluated the stature increase of
phenylketonuric children in terms of 'control" as
defined in the chapter on methodology.

Again the research

hypothesis was rejected as no significant difference was
found between the last measured heights of those under
"good” control and those under "poor" control.

Thus, the

state of control of the treated phenylketonuric child
did not make any difference in growth, when height was
the parameter used as a measure.
Hypothesis IV
When the group whose treatment was started at or
before six months of age In "good" control and the group
whose treatment was started after 6 months of age In
"poor" control were compared with those whose treatment
was started at or before six months of age in "poor"
control and those whose treatment was started over six
months of age in "good" control, no significant difference
was found in terms of their last measured height.

Again
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It was shown that control and/or time of beginning of
treatment had no effect on later height of phenylketonurlc
children.
Skeletal Age
There were 40 children for whom one or more skeletal
ages were available,

Of this number, 22 had a normal bone

age, 9 had a retarded bone age, and 9 had reports of both
normal and retarded bone age.

In the latter group, four

were retarded at beginning of treatment and later normal,
five were normal at beginning of treatment and were later
retarded.

Three of those who were normal at beginning of

treatment and later retarded had returned to normal on a
subsequent x-ray.

In one child treatment began at 10

months of age but at 3 years 5 months there was a retarded
bone age, however, this returned to normal three months
later.

Another child whose treatment began at 8 months

had a retarded bone age at 3 years 9 months; this also
returned to normal when he was 4 years 4 months old.
An Interesting observation was that those having
both normal and retarded bone age ratings fell within
the group who were 24 months or younger at time treatment
was instituted.

This change in skeletal age probably

reflects a growth pattern normal for those children.
Table I shows the bone age scores on these phenylketonurics.
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TABLE I
SKELETAL AGE SCORES ON FORTY
PHENYLKETONURIC CHILDREN

Normal

Number

Per cent

22

55.00

9
9

22.50

Retarded
Normal and Retarded
Retarded at beginning of treatment
Normal at beginning of treatment

22.50

4
5*

♦Of this group, 3 had returned to normal on a subsequent
-measure.
II.

NUTRITIONAL DATA

Table II gives the means for serum phenylalanine
level, dietary phenylalanlne, protein, and caloric intakes
for each of the age Intervals.

In the first Interval, the

mean age was 2.3 months with a standard deviation of 0.65
indicating that there were no measures for children under
approximately six weeks of age.

This material Is

graphically presented in Figures 2, 3, and 4.
Mean serum phenylalanine levels ranged from 1.4 to
2.8 milligrams per cent and Indicated that the children
were in good control.

However, this was inherent In the

data selected since the criteria for use of the measure
was that serum phenylalanine level be equal to or less

TABLE 11
MEAN SERUM PHENYLALANINE LEVELS AND MEAN PHENYLALANINE, PROTEIN, AND CALORIC
INTAKE FOR PHENYLKETONURIC CHILDREN OF VARYING AGES*

AGE
N

w
Months

Mean
Age

SD

MEAN PHENYLALANINE (mgs)
Serum
Intakes
Per
Per
Mg.
SD
Day SD
lb.

SD

MEAN PROTEIN INTAKE
(grams)
Per
Per
Day
SD
lb.

MEAN CALORIC INTAKE
SD

Per
Day

SD

Per
lb.

SD

12

0 4 3

2.3 0.65

1.9

0.86

22?

71

19.3

5.53

20.8

5.88

1.76

0.1.2

611

182

53.6

1U.0

7

li ? 6

5.1

0.69

2.6

2. [j.0

259

91

16.9

3.89

20.1*

U.60

1.18

0.53

661*

11*5

1*1*. 7

6.1*

11

7 T 9

8.1

0.9U

2.8

2.20

288

57

15.1*

3. hi*

25.1*

6.30

1.31*

0.28

856

11*8

1*5.8

6.8

1* 10 Xl2

11.0

1.15

1.1* 1.1*0

271

78

ll*.3

3.10

25.3

2.50

1.30

0.13

866

126

1*5.3

5.3

hO 13 X 36

22.9

6.60

2.0

1.75

296

169

12.0

2.87

30.8

8.10

1.25

0.27

1086

271*

1*3.9

9.1

38

37 T 72

51.1

8.53

2.7

2.10

1*05

161*

10.5^

3.50

1*1.7^

10.80

1.10y 0.26

1569Z

312

1*2.5Z

6.9

17

73<~108

87.0

6.52

2.5

1.90

1*88

221*

9.7X

3.91

1*5.7X 12.10

0.95x

1817x

1*65

37.8X

8.9

0.25

*Data in this table are only for those children -who had serum phenylalanine levels less than or equal to
six milligrams per cent at the time of the measure.
Note:

w
x
y
z

Age intervals in months
N = 16
N = 36
N = 37

■<1

48
850-’
80Qi
Caloric Intake 75
per day

TOO

65a
6ocr
2
2^i

Protein Intake
gms/day

a
2
2
1
28S

Phenylalanine
Intake
mgs/day

2754

26525^!

245-'
2 34
225-

2.a
Serum
Phenylalanine

2 c
*

2.2-3
mgs /

1.9J
1.

Age in Months

7
0 < 3

4 < 6

7 < 9

10 < 12

FIGURE 2
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than six milligrams per cent,

Mean phenylalanine intakes

were from 227 to 488 milligrams per day with standard
deviations of 57 to 224 milligrams.

Phenylalanine

Intakes based on the child*s weight ranged from 19.3
milligrams per pound each day for Group 1, to a low of
9.7 milligrams per body weight In Group 7*

Standard

deviations were greatest in the youngest group.

Total

daily phenylalanine Intake was greatest in the oldest
children, but the youngest children had the highest
intake when this intake was based on milligrams per pound
of body weight.
The data for protein intake as grams of protein
per day and as grams of protein per pound of body weight
each day is given in Table II,

Group 1 had a mean dally

intake of 20.8 grams of proteinj Group 2, 20.4; Group 3,
25.4; Group 4, 25.3j Group 5, 30.8; Group 6, 41.7; and
Group 7, 45.7.

Standard deviations ranged from 12,1 in

the oldest age group to 2.5 In Group 4, however, this
group had the smallest number of measures.

When the

protein intake was figured on the basis of grams per
pound of body weight each day, a high of I.76 grams was
observed in the youngest age group with a gradual
decrease to O.95 grams in the oldest age group.
Caloric Intake ranged from a high of 1817 calories
each day for ages 73-108 months, to a low of 6ll for the
infants as shown in Table II, page 47.

Calories per

pound of body weight each day were in inverse order;
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the youngest consumed the greatest number per weight
(53.6).

Groups 2, 3, 4, 5, and 6 had intakes of 44.7,

45.8, 45.3, 43.9, and 42.5 calories per pound, respect
ively.

The oldest group had an intake of 37.8 calories

for each pound of weight, about 5 calories less than the
group immediately preceeding.

The standard deviation

for calories in Group 1 was 14.0 calories per pound each
day.

This was in line with other reports in the liter

ature that there were great differences between individuals of the same age as to caloric consumption, ^

In the

older age groups, the standard deviations were not as
large; this too was in line with previous findings that
there was less change in children from age one year
until the pre-pubertal spurt than in the infant.

Probably

none of the children had reached this age, since the data
Included only those up to nine years of age.
In Table III, the intake of phenylalanine per
pound of body weight daily was compared with the amounts
recommended by Acosta.'*-

The means for Groups 1, 2, and

4 were below her recommended amounts, the means for
Groups 3 and 5 were within the recommended amounts, and
the means for Groups 6 and 7 were slightly higher than
those recommended.

However, these two age groups obtained

more protein from sources other than the casein hydrol
ysate and the method of arriving at this nutrient data
has been changed since July, 1965.

If the more recent

TABLE III
MEAN PHENYLALANINE, PROTEIN, AND CALORIC INTAKES COMPARED
WITH RECOMMENDED ALLOWANCES*

Age
Intervals
In Months

N

Phenylalanine
mgs./pound
Ref. 1

Study

Protein
gms./day N R C 89

Protein
gms./lb./day

Study

N R C

Study

Calories
per day

N R C

Calories/
pound/day

Study

N R C

Study

12

0 £ 3

IjO - 20

19.3

20.8

1.1k

1.76

611

52.3

53.6

7

hZ 6

liO - 20

16.9

20.U

l.lli

1.18

661;

52.3

UU.7

11

7 g 9

20 - 15

15.li

25.U

l.lli

1.3U

856

52.3

U5.8

U

10 £ 12

20 - 15

lU.3

25.3

l.lU

1.30

866

52.3

U5.3

liO

13 Z 36

15 » 10

12.0

32

30.8

1.25

1300

1086

U3.9

36

37 Z 72

10-7

10.5

UO

Ul.7

1.10

1600

1569z

U2.5

16

73 £108

7 - 5

9.7

52

U5.7

0.95

2100

1817

37.8

z

N = 37

* Data in this table are only for those children who had serum phenylalanine levels less than or equal
to 6 milligrams per cent at the time of the measure.
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method of calculation had been used throughout it is
possible that calculated phenylalanine intake might be
lower.

The analytical data for phenylalanine content

is lower in some foods than originally calculated on
the basis that all protein contains five per cent of the
amino acid phenylalanine.
The comparison of protein Intake for the study
group with that recommended by the National Research
84
Council
is shown in Table III. The protein intake in
the youngest group was considerably higher than the
recommended allowances.

Prom the age of three months

to one year the intake was higher, though by a fairly
small margin.

At the age of 13-36 months, the intake

was slightly less, being 30.8 grams compared with 32
grams recommended.

Those in Group 6 had slightly more

than the recommended Intakes and Group 7 consumed approxi
mately six grams of protein less than recommended.
Calories per pound of body weight each day for
Group 1 was above the National Research Council Recommended
Allowances by a slight margin; for all other groups,
calories were less than those recommended.

Evidently

then the phenylketonuric children did not follow the
usual pattern of ingesting more calories than recommended
by the National Research Council as did the normal
children in the studies of Burke 19 and Rueda-Williamson. 88
This might be due to one of many factors.

One factor to
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be considered was the necessity for strict control of the
diet which would militate against high food consumption
because of less variety and less opportunity for con
suming high caloric foods due to snacking.

Another

factor was that the diet averages of the study were
based on recorded intakes, while those of other studies
have been based on "recall" histories; there could very
well be a difference in the end results due to the two
different methods of securing the data.

These data are

graphically presented in Figures 2, 3* and 4, pages 48,
49, and 50.

The nutritional data was selected for

inclusion only if the simultaneous serum phenylalanine
was equal to or less than 6 milligrams per cent.

CHAPTER V
SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS
Forty-eight children treated for phenylketonuria
were selected for study to determine If the growth of
the children was different from the growth of the normal
child population.

Since heredity plays such a large

part in the stature of an individual, the parents*
heights were compared with the adult white American.
The heights of both father and mother were above
that of the adult white American, however, the difference
was very small, being 0.15 and 0.32 Inches, respectively.
The mean of the last reported height for the
treated phenylketonuric children compared with the
expected mean height for norms showed that the children
were 1.4 Inches shorter; when this difference was tested
statistically for significance, the results showed that
there was a probability of only 1:1,000 that the results
could have occurred by chance.

Thus, it was concluded

that treated phenylketonuric children are shorter than
normal children.

It was also shown that degree of control

(of serum phenylalanine level) and the time of beginning
treatment had no influence on the last heights of the
treated phenylketonuric children.
Phenylalanine intake varied with the children and
with the ages of the children.
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The intake based on body
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weight was at a maximum for the early age group,

Protein

intake in the infant to three months of age was consid
erably above the National Research Council Recommended
Allowances, the intake of 3-12 and the 37-72 month old
groups were only slightly above the recommendations,
whereas in the ages of 13-38 and 73-108 months, protein
Intake was somewhat lower than the recommendations.
Calorie intake was slightly higher than the recommenda
tions only in the 1-3 month old group.
The following recommendations were made for
further research based on the results and limitations of
this study:
1.

Definite protocol be established regarding

techniques to be used in securing the anthropometric
measures.

Height and/or length should be taken in a

specific manner with a fixed age at which to begin using
standing height; clothing should not be a factor in the
weight measure.
2.

In addition to height and weight, stem length.

bicristal and bisacromial measures should be taken to
allow for the study of the body proportions of the phenyl
ketonuria.
3.

Evaluation of the physical status of siblings.

4.

Evaluation of anthropometric data on all known

untreated phenylketonurics.
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5.

The anthropometric measurements be taken at

constant Increments of time and if at all possible, these
to be taken on the birthdate, the half year date, etc.

6. Further effort be made to secure more complete
data in all areas.
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Data from forty-eight medical records of phenyl
ketonuria children under treatment were investigated to
determine if growth, as measured by stature, was normal;
and to determine if the state of control or the age at
beginning of treatment had an effect on growth.

Mean

intakes of phenylalanine, protein, and calories were
obtained on the nutritional data only if the silumtaneous
serum phenylalanine was equal to or less than 6 milligrams
per cent.

These means were grouped according to the age

of the children into 7 groups (Ck3, ^£6, 7<9, 10<12, 13<36,
37<J2, and 73<108 months).
The height at beginning of treatment and the last
measured height was compared with established norms of the
Brush Foundation Study.

To determine whether the state of

control or age of beginning treatment were factors in
growth, the children were divided into groups according to
(1) age dietary treatment was instituted (equal to or less
than six months and over six months), and (2) state of
control.

"Good” control for this part of the study was

having serum phenylalanine levels equal to or less than
4 milligrams per cent 75 P@r cent of the time, and "poor"
control, those having levels over 4 milligrams per cent
75 per cent of the time.
The mean height of the parents compared favorably
with the mean height for the white American male and
female.

At beginning of treatment the children were

approximately half an inch shorter than estimated norms
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but at their last measured height they were 1,40 inches
shorter.

When the last recorded heights of the phenyl-

ketonuric children were analyzed considering time of
beginning of treatment and state of control during
treatment, there was no significant difference between
the groups.
The mean phenylalanine intake ranged from 227 to
488 milligrams each day.

On a pound basis Group 1 con

sumed 19.3 milligrams per pound, with a gradual decrease
to a low of 9.7 milligrams per pound in the 73 to 108
month age group.

Protein intakes ranged from 20.8 grams

a day for Group 1 to 45.7 grams each day for Group 7.
The protein intake of the youngest group was above that
recommended by the National Research Council, Groups 2,
3, 4, and 6 intakes were only slightly above the recommen
dations, Groups 5 and 7 had a somewhat lower intake than
recommended.

Mean caloric intake ranged from 6ll to 1817

calories each day, increasing with increasing age.
Calorie intake in Group 1 was 53*6 calories per pound of
body weight.

This was slightly higher than the recommended

allowances.

All other groups had mean calorie intakes less

thah those the National Research Council recommends.
It was concluded that treated phenylketonuric children
are significantly shorter than established norms but that
age at beginning of treatment and control during treatment
had no influence on the last heights of the children.
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